|
|
cation homeostasis
|
GO:0055080 |
212 |
0.286
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.156
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.151
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.143
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.136
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.135
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.132
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.131
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.125
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.125
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.121
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.109
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.109
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.106
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.106
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.102
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.101
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.097
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.087
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.082
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.081
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.079
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.079
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.078
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.077
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.076
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.075
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.073
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.072
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.070
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.069
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.068
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.067
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.066
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.066
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.064
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.064
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.064
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.063
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.062
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.062
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.061
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.060
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.060
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.058
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.058
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.058
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.057
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.057
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.057
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
3 |
0.056
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.055
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.055
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.055
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.054
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.054
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.054
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.053
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.053
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.053
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.052
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.052
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.052
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.051
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.051
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.051
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.050
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.050
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.048
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.046
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.046
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.045
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.044
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.044
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.044
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.044
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.044
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.044
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.044
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.044
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.044
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.043
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.042
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.041
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.041
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.041
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.041
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.041
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.040
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.040
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.039
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.039
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.039
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.039
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.038
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.038
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.038
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.037
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.037
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.037
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.036
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.036
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.036
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.036
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.036
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.035
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.035
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.035
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.035
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.035
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.035
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.035
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.034
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.034
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.034
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.033
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.033
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.033
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.031
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.031
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.031
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.031
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.031
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.030
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.030
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.030
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.030
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.029
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.029
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.029
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.028
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.028
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.028
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.028
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.028
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.027
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.027
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.027
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.027
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.027
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.027
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.027
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.026
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.026
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.026
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.026
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.026
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.026
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.025
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.025
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.025
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.025
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.025
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.025
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.024
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.024
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.024
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.024
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.024
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.024
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.023
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.023
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.023
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.023
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.023
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.022
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.022
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.022
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.022
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.022
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.022
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.022
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.022
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.022
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.021
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.021
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.021
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.021
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.021
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.021
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.021
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.020
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.020
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
negative regulation of cation channel activity
|
GO:2001258 |
1 |
0.020
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.020
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.020
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.020
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.020
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.019
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.019
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.019
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.019
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.019
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.019
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.019
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.018
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.018
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.018
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.018
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.018
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.018
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.018
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.018
|
|
|
|
regulation of substrate adhesion dependent cell spreading
|
GO:1900024 |
12 |
0.018
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.018
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.017
|
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.017
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.017
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.017
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.017
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.017
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.017
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.016
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.016
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.016
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.016
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.016
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.016
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.016
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.016
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.016
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.016
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.016
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.015
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.015
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.015
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.015
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.015
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.015
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.015
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.015
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.015
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.015
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.015
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.015
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.015
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.015
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.015
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.015
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.014
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.014
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.014
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.014
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.014
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.014
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.014
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.014
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.014
|
|
|
|
icosanoid transport
|
GO:0071715 |
14 |
0.014
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.014
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.014
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.014
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.014
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.014
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.014
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.014
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
11 |
0.014
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.013
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.013
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.013
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.013
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.013
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.013
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.013
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.013
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.013
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.013
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.013
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.013
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.013
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.013
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.013
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.013
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.013
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.013
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.013
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.013
|
|
|
|
fatty acid derivative transport
|
GO:1901571 |
14 |
0.013
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.013
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.013
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.013
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.013
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.012
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.012
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.012
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.012
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.012
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.012
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.012
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.012
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.012
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.012
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.012
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.012
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.012
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.012
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.012
|
|
|
|
negative regulation of leukocyte apoptotic process
|
GO:2000107 |
31 |
0.012
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.012
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.012
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.012
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.012
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.012
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.012
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.012
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.012
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.012
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.012
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.012
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.012
|
|
|
|
sensory perception of touch
|
GO:0050975 |
2 |
0.012
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.012
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.011
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.011
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.011
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.011
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.011
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.011
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.011
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.011
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.011
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.011
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.011
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.011
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.011
|
|
|
|
negative regulation of b cell apoptotic process
|
GO:0002903 |
7 |
0.011
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.011
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.011
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.011
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.011
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.011
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.011
|
|
|
|
negative regulation of ryanodine sensitive calcium release channel activity
|
GO:0060315 |
1 |
0.011
|
|
